Manulife (Manufacturers Life Insurance)
NGNE icon

Manulife (Manufacturers Life Insurance)’s Neurogene NGNE Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-14,079
Closed -$322K – 2964
2024
Q4 		$322K Buy
+14,079
New +$524K ﹤0.01% 2419
2022
Q1 		– Sell
-1,006
Closed -$97 – 3147
2021
Q4 		$97 Buy
1,006
+427
+74% +$52K ﹤0.01% 3055
2021
Q3 		$84K Sell
579
-488
-46% -$74.7K ﹤0.01% 3107
2021
Q2 		$197K Buy
1,067
+116
+12% +$25.7K ﹤0.01% 3115
2021
Q1 		$234K Sell
951
-36
-4% -$9.2K ﹤0.01% 2785
2020
Q4 		$278K Buy
987
+105
+12% +$25.7K ﹤0.01% 2566
2020
Q3 		$212K Hold
882
– – ﹤0.01% 2526
2020
Q2 		$267K Buy
+882
New +$230K ﹤0.01% 2329

Other funds holding NGNE

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s NGNE Position: Q1 2025 in Review

Manulife (Manufacturers Life Insurance) sold out of Neurogene (NGNE) in Q1 2025, closing a stake of 14,079 shares — an estimated $322K sold.

Manulife (Manufacturers Life Insurance) first reported a position in NGNE in Q2 2020 and held it in 8 quarters. The position peaked at $322K in Q4 2024. 85 funds tracked by Wall St. Rank hold NGNE as of Q1 2025.

  • Manulife (Manufacturers Life Insurance) reported no remaining Neurogene position as of Q1 2025 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 14,079 Neurogene shares in Q1 2025, an estimated $322K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Neurogene in Q2 2020 and held it in 8 quarters.
  • Manulife (Manufacturers Life Insurance)'s Neurogene position peaked at $322K in Q4 2024.
  • 85 funds tracked by Wall St. Rank held Neurogene as of Q1 2025.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2025, filed 15 May 2025.